WALT ACQU Nasdaq

Equities

WALD

KYG9460C1006

Other Specialty Retailers

Market Closed - Nasdaq 04:30:01 2024-03-28 pm EDT 5-day change 1st Jan Change
6.5 USD +1.56% Intraday chart for WALT ACQU -9.99% -12.16%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Waldencast Regains Compliance With Nasdaq's Filing Requirements MT
Telsey Advisory Cuts Waldencast Acquisition's Price Target to $10 From $12, Keeps Outperform Rating MT
Wall Street Set to Open Higher After Fed Holds Interest Rates Steady; Initial Jobless Claims Lower Than Expected MT
Waldencast plc Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Obagi Cosmeceuticals LLC Announces the Launch of Daily Hydro-Drops Rejuvenating Eye Gel Cream CI
Waldencast Appoints New Chief Financial Officer MT
Waldencast plc Announces Philippe Gautier Leaves the Company as Chief Operating Officer CI
Waldencast plc Announces Chief Financial Officer Changes CI
Telsey Advisory Adjusts Waldencast's Price Target to $12 From $13, Keeps Outperform Rating MT
Waldencast plc Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Waldencast Receives Additional Non-Compliance Notice MT
Waldencast plc announced that it expects to receive $70 million in funding from Beauty Ventures LLC and other investors CI
Raymond James Downgrades Waldencast Acquisition to Market Perform From Outperform MT
Waldencast Signs Letter of Intent to Acquire 60% of Southeast Asia Distributor; Moves Q4 Earnings Release Date to April 26 MT
Waldencast plc Reports Earnings Results for the Two Months Ended September 30, 2022 CI
Waldencast plc Reaffirms Sales Guidance for the Fiscal 2022 CI
DA Davidson Adjusts Price Target on Waldencast Acquisition to $15.50 From $12, Maintains Buy Rating MT
Waldencast Posts Higher Q3 Adjusted EBITDA; Reiterates 2022 Outlook MT
Waldencast plc Reaffirms Earnings Guidance for the Fiscal Year 2022 CI
Waldencast Hires Philippe Gautier CFO, COO MT
Waldencast plc Announces Executive Changes CI
Waldencast plc Appoints Philippe Gautier as the Chief Financial Officer, Effective October 19, 2022 CI
DA Davidson Starts Waldencast at Buy with $12 Price Target MT
Raymond James Starts Waldencast Acquisition at Outperform With $11 Price Target MT
Jefferies Starts Waldencast Acquisition at Buy With $11 Price Target MT
Chart WALT ACQU
More charts
Waldencast plc operates a global multi-brand beauty and wellness platform. The Company is focused on developing, acquiring, accelerating, and scaling conscious and purpose-driven brands. The Company’s segments include Obagi Skincare and Milk Makeup. Obagi Skincare is an advanced skin care line rooted in research and skin biology. Obagi products are designed to diminish the appearance of premature aging, photodamage, skin discoloration, acne, and sun damage. Obagi offers over 200 products through physicians and its Website, www.obagi.com throughout the United States as well as in over 65 countries through international distributors. Milk Makeup creates vegan, cruelty-free, clean formulas and offers over 300 products through its United States Website, www.milkmakeup.com, and its retail partners, including Sephora in North America, Europe, the Middle East, Australia, Cult Beauty, and ASOS online. Its subsidiaries include Obagi Global Holdings Limited and Milk Makeup LLC, and others.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
6.5 USD
Average target price
10 USD
Spread / Average Target
+53.85%
Consensus
  1. Stock
  2. Equities
  3. Stock Waldencast plc
  4. Stock WALT ACQU - Nasdaq
  5. News WALT ACQU
  6. Waldencast Acquisition to Merge With Skin Care Brands Obagi, Milk Makeup in $1.2 Billion Deal